The laboratory is currently developing new ways to incorporate 11C and 18F radionuclei, expanding the arsenal of radiopharmaceuticals applied to biologic problems. We recently developed (Liu et al, Chem 2021) a new method of fluorine incorporation into amide structures that is currently under investigation in our laboratory for 18F labeling of amino-acids and their derivatives.
